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Protamine sulfate often causes hypotension during heparin neutralization. 
The concept of ventricular-arterial coupling was applied to determine 
whether a negative inotropic effect or a vasodilating effect of protamine was 
the major contributing factor to this hypotension. Thirty-five patients who 
underwent cardiac operations were studied during operation by measuring 
instantaneous left ventricular pressure and aortic flow to examine the 
end-systolic pressure-volume relationship. We obtained end-systofic elas- 
tance and effective arterial elastance values in a beat-to-beat fashion with a 
single-beat estimation method. In 28 of the 35 patients (80%), mean arterial 
pressure decreased more than 10 mm Hg with protamine infusion. Param- 
eters were compared at the following three points: before a decrease in 
mean arterial pressure (control), at maximally decreased mean arterial 
pressure (maximum), and at a middle point between control and maximum 
values (midpoint). At both midpoint and maximum, mean arterial pressure 
decreased significantly (control 79.6 -+ 12.6 mm Hg, midpoint 66.5 +_ 10.8 
mm Hg, maximum 52.7 - 9.9 mm Hg; p < 0.01). Similar changes were 
observed in effective arterial elastance (control 2.00 - 0.75 mm Hg/ml, 
midpoint 1.60 ~ 0.53 mm Hg/ml, maximum 1.31 -+ 0.46 mm Hg/ml; p < 
0.01). Although the decrease in end-systolic elastance at midpoint (control 
3.08 - 1.61 mm Hg/ml, midpoint 2.92 -+ 1.68 mm Hg/ml) did not reach 
statistical significance, end-systolic elastance significantly decreased at 
maximum (2.63 - 1.46 mm Hg/ml; p < 0.01). Continuous measurements 
showed that the decreases in mean arterial pressure and effective arterial 
elastance always preceded the depression of end-systolic elastance and that 
afterload reduction by vasodilating effect of protamine was the mechanism 
most likely to have initiated the hypotension. Delayed decrease in contrac- 
tility may be ascribed to reduced coronary perfusion pressure caused by 
vasodilation or to a direct effect of protamine. (J Thorac Cardiovasc Surg 
1996;112:462-71) 
p rotamine sulfate has been used after cardiopul- 
monary bypass (CPB) to neutralize anticoagula- 
tion induced by heparin. Adverse cardiovascular 
effects of protamine, including hypotension, anaphy- 
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lactoid reactions, and catastrophic pulmonary vaso- 
constriction, have been reported. 1 Among these 
responses, hypotension is frequently observed. Such 
hypotension during the critical postoperative period 
may cause detrimental hemodynamic changes if an 
appropriate intervention is not given. It has been 
suggested that this hypotension may result either 
from a vasodilating effect or from a negative inotro- 
pic effect of protamine. Despite the large number of 
studies, 213 it has not been clear which of the two, 
vasodilation or reduced contractility, contributes 
quantitatively more manner to hypotension. 
Ventricular-arterial coupling is a concept built on 
the framework of the ventricular pressure-volume 
relationshipJ 4 This concept enables one to evaluate 
the specific contribution of the end-systolic proper- 
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ties of the ventricle and parameters of the arterial 
system to stroke volume (SV) and end-systolic pres- 
sure (Pes)" Arterial and left ventricular Pes can be 
predicted from a simple equation consisting of three 
parameters representing preload (end-diastolic vol- 
ume, Ved), afterload (effective arterial elastance, 
Ea), and systolic function (slope of the end-systolic 
pressure-volume r lationship, ESPVR).  Continuous 
assessment of the ESPVR has not been possible, 
however, because simultaneous measurements of 
both pressure and volume in various loading ven- 
tricular contractions are usually required to obtain 
ESPVR. To measure ESPVR continuously in the 
operating room, we used a method of estimating 
ESPVR from a single ejecting beat without measur- 
ing ventricular volume in a beat-to-beat fashion. 15' ~6 
The purpose of this clinical study was to investigate 
whether a negative inotropic effect or a vasodilating 
effect of protamine was the major contributing 
factor to the hypotension. We attempted to quantify 
the contribution of each parameter to protamine- 
induced hypotension. 
Table I. Patient profile 
Hypotension No hypotension 
(n =28) (n - 7) 
Sex (M/F 15/13 2/5 
Age (yr) 40.3 ± 13.3 53.7 ± 8.8* 
NYHA 1.8 ± 0.7 2.0 ± 0.6 
CTR (%) 53.5 _+ 7.0 61.4 ± 4.24 
EF (%) 59.4 +_ 13.7 50.0 ± 11.7 
Operation 
ASD 9 2 
OMC 6 1 
MVR 4 1 
AVR 6 3 
Other 3 0 
AXT (rain) 61.6 ± 29.9 70.1 ± 32.3 
CPBT (min) 101.1 _+ 40.2 116.7 ± 44.6 
NYHA, New York Heart Association functional class; CTR, cardiothoracic 
ratio; EF, ejection fraction; ASD, direct or patch closure of atrial septal 
defect; OMC, open mitral commissurotomy; MVR, mitral valve replace- 
ment; AVR, aortic valve replacement; Other, extirpation of left atrial 
myxoma, left ventricular myectomy, anbd membranectomy of right ven- 
tricular outflow tract; AXT, aortic crossclamp time; CPBT, cardiopulmo- 
nary bypass time. Values are mean ~ standard eviation. 
*p < 0.05 by unpaired t test. 
~'p < 0.01 by unpaired t test. 
Methods 
Patients. Thirty-five patients who underwent elective 
cardiac operations were studied (Table I). The study proto- 
col was approved by the Human Subjects Committee of our 
institution. Informed consent was obtained from all patients. 
Instrumentation. A radial arterial line and a central 
venous line were inserted. Before CPB was begun, each 
patient received intravenous heparin (3 mg/kg). Multidose 
cold (4 ° C) oxygenated erystalloid potassium cardioplegic 
solution was used for myocardial protection, as described 
elsewhere. ~y In addition, topical cooling with iced lactated 
Ringer's solution and moderate systemic hypothermia 
(28.4 ° ± 2.5 ° C) was employed. At the end of CPB, a 
micromanometer (model MPC-500; Millar Instruments, 
Inc., Houston, Texas) was inserted into the left ventricle 
through the roof of the left atrium or the ascending aorta. 
The time derivative of the left ventrieular pressure signal 
(dP/dt) was calculated by a differentiator (model 1323; 
Nihon Koden, Tokyo, Japan). An appropriately sized 
electromagnetic flow probe (model FR series; Nihon 
Koden) was placed around the ascending aorta, proximal 
to the arterial cannulation site. The venous drainage 
eannula was then removed, and major bleeding from the 
heart and great vessels was surgically corrected. From 5 to 
35 minutes (14.8 _+ 9.5 minutes) after the end of CPB, 
when the patient was in hemodynamieally stable condi- 
tion, protamine sulfate (3 mg/kg) was infused from the 
central venous line over 3 minutes at a constant rate. 
Data analysis. The electrocardiogram, arterial pres- 
sure, central venous pressure (CVP), left ventricular 
pressure, aortic flow, and dP/dt were displayed on an 
eight-channel chart recorder (Polygraph 360 system; NEC 
San-el, TOkyo, Japan) and were stored on a tape (MR-30; 
TEAC, Tokyo, Japan). All recorded signals were appro- 
priately calibrated and digitized off line at a sampling 
interval of 5 msec. The stored signals were analyzed by a 
program developed in our laboratory with a signal-pro- 
cessing computer system (7T17; NEC San-el). 
We used a method of estimating ESPVR from a single 
ejecting beat 15' 16 to follow the serial hemodynamic 
changes. As shown in Fig. 1, if we obtain left ventricular 
peak isovolumic pressure (Pmax) from a given ejecting 
beat, a tangential line can be drawn from the Pmax point to 
the left upper corner of the left ventricular pressure- 
volume loop, which yields ESPVR. The slope of this line 
represents end-systolic e las tance  (Ees). 18' 19 We estimated 
Pmax from a pressure curve during isovolumic ontraction 
period. By means of the Gauss-Newton onlinear least- 
square method, the pressure curve was fitted to the 
following equationZ°: 
HMP(t )  = 1~.  DPmax " (1 - cos (ot) + Ped (1) 
where HMP is hydromotive pressure, which reflects the 
pressure wave of nonejecting beat, DPmo~ is maximum 
developed pressure, Pea is left ventricular end-diastolic 
pressure, ~o is 2~r/T (in which T is the duration of 
contraction), and t is time. Originally, data from both 
isovolumic ontraction and the relaxation phase of the 
ejecting beat were used. 2° We made the estimate with only 
the data of isovolumic contraction phase, however, be- 
cause of the afterload dependency of pressure curve 
during the relaxation phase. 21 Once Pmax was  estimated, 
the ESPVR line was drawn from the point of Pmax at 
arbitrarily set Vod to the left upper corner of the pressure- 
volume loop of the ejecting beat. The pressure of this left 
upper corner represented left ventricular Pes. The trajec- 
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Fig. 1. Principle used to assess Ee= and E a from a single ejecting beat. Lefipanel." Estimation of Pmax" The 
solid line shows a measured ejecting beat. The left ventricle was assumed as a linear time varying 
hydromotive pressure source, HMP(t). By fitting the isovolumic ontraction portion of the measured left 
ventricular pressure (LVP) to the function described at the bottom of the figure (equation 1), estimated 
isovolumic LVP (dashed line) and P . . . .  were obtained. Right panel: Estimation of E~s and E a. The line 
connecting the estimated Pmax point to the left upper corner (P~s) of the pressure-ejected volume loop that 
was obtained by integration of aortic flow yields the slope of ESPVR (E~s) and V¢ (Ved -- Vo). E= is the 
slope of the P~s-SV relationship. 
tory of the pressure-volume loop was obtained by plotting 
left ventricular pressure and the time integral of the 
ejected flow subtracted from Ved: Veal -- f~ flow(t)dt. 
Because V~d was an arbitrarily set number, we did not 
know the absolute value of the volume axis intercept of 
ESPVR line (Vo). The difference between V~d and Vo, 
however, which we term "effective nd-diastolic volume," 
or  g e (Ved -- V0)  , was  available. E a was  calculated as 
Pes /SV.  14 
Other hemodynamic parameters uch as heart rate 
(HR; 60/cycle lengths), mean arterial pressure (MAP), 
Peal, cardiac index (CI; SV. HR/body surface area), and 
systemic vascular esistance (SVR; [MAP - CVP]-80/ 
cardiac output) were also determined in a beat-to-beat 
fashion. When we thought arterial pressure had reached a
nadir, we slowly infused volume while being careful to 
avoid overinfusion. Comparisons of hemodynamic param- 
eters were conducted at the following three points; just 
before MAP started to decrease after the infusion of 
protamine (control), when MAP was maximally decreased 
before volume loading (maximum), and at the middle 
between control and maximum (midpoint). At each point, 
the hemodynamic values of 5.4 _+ 2.6 consecutive beats 
were averaged. 
Evaluat ion of  the effect of each parameter  on hypoten-  
sion. First, we analyzed relationships between percentage 
changes from each control value in MAP and changes in 
each parameter during hypotension. 
Second, from the concept of ventricular-arterial cou- 
pling, the following equations were obtained (Fig. 1): 
Po= = ECs" (V~s - Vo) (2) 
Pos = E , .  SV (3) 
SV = V~a - V,, (4) 
V e = Ved -- V 0 (5)  
where Ves is end-systolic volume. From these equations, 
the following equation is obtained: 
Ees • Ea 
Pes = (E~s + Ea) 
ges " Ea 
- -  " (Ved -- V0) = (E~s + E=) .vo 
(6) 
With this equation, we evaluated the effect of parameters 
including contractility (Ees), afterload (Ea) , and preload 
(V~) on the degree of hypotension. The values of one 
parameter at midpoint and maximum were substituted in
this equation, leaving the other parameters set to the 
control value. For example, the effect of Ees at midpoint 
on Pc= was calculated as follows: 
APes(ges,Mid) = (Pes at Ees.Mid ) -- Pes,cont 
Ees,Mid • Ea,cont 
(Ees,Mid -}- Ea,cont 
• Ve,cont -- Pes,Cont (7)  
where Ees, Mid is a value of Ee= at midpoint and E,~,con t, 
Ve, c ..... and Pes, Con* are the control values of those param- 
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eters. The difference between P~ at Eos, Mia and Pes,Cont 
was obtained to quantify the effect of that parameter on 
Pes. 
Compression of the femoral arteries. The results of this 
study in the first several patients suggested that the 
protamine-induced hypotension in these patients was 
caused mainly by the decreased afterload. We therefore 
presumed that protamine-induced hypotension could be 
reversed by increasing afterload. To increase afterload, we 
compressed the bilateral femoral arteries with the fists 
during the hypotensive period in seven patients rather 
than performing volume loading. Data obtained before 
and after compression of the femoral arteries were com- 
pared. 
Statistical methods. Measured values were expressed 
by mean and :standard eviation. A repeated-measures 
analysis of variance was used to examine the differences 
among the parameters atthe three points. Ap value less 
than 0.05 was considered to be statistically significant. If 
an overall difference was present, Bonferroni's adjustment 
was performed. 22Comparisons of the data before and 
after compression of the femoral arteries were conducted 
by paired t test. Multiple linear regression (least squares) 
was used to correlate the changes of MAP with those of 
other parameters. 
Results 
Clinical profiles of the patients studied. Table I 
summarizes preoperative and operative profiles of 
the studied patients. Of 35 patients studied, 28 
patients (80%) showed a decrease in MAP greater 
than 10 mm Hg during protamine administration. 
More advanced age and larger hearts were noticed 
in the patients without protamine-induced hypoten- 
sion. In seven of 28 hypotensive patients, flow 
signals were not available because of electrical 
noise. Consequently, we analyzed a total of 21 
patients who showed protamine-induced hypoten- 
sion. Their body weights and body surface areas 
averaged 55.2 _+ 8.7 kg and 1.56 _+ 0.17 m 2, respec- 
tively. 
Representative tracing of hemodynamic parame- 
ters. In each case, there was no change in hemody- 
namic parameters during the protamine infusion 
before MAP started to decrease. Representative 
changes of hemodynamic parameters during prota- 
mine-induced hypotension i a beat-to-beat fashion 
are shown in Fig. 2. In this case, initial decrease in 
MAP was observed at 50 seconds after protamine 
administration, and MAP was maximally decreased 
within next 20 seconds. Marked decreases in SVR 
and E a were observed in association with the de- 
crease in MAP. On the other hand, CI increased 
slightly. The other hemodynamic parameters were 
relatively unchanged. 
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Fig. 2. Representative changes of hemodynamic param- 
eters during protamine-induced hypotension i a beat-to- 
beat fashion. 
Changes in hemodynamic parameters during 
protamine-induced hypotension. The changes in 
hemodynamic parameters during protamine-in- 
duced hypotension are shown in Fig. 3. MAP started 
to decrease 81 -- 32 seconds after protamine admin- 
istration was begun, and the maximum decrease in 
MAP occurred at 115 + 38 seconds. A repeated- 
measures analysis of variance revealed significant 
decreases (p < 0.01) in MAP, SVR, Ea, and Ees. At 
both midpoint and maximum, MAP decreased sig- 
nificantly (control 79.6 +_ 12.6 mm Hg vs midpoint 
66.5 + 10.8 mm Hg, p < 0.01; control vs maximum 
52.7 _+ 9.9 mm Hg, p < 0.01; and midpoint vs 
maximum, p < 0.01). Similar trends were observed 
in changes of SVR (control 1359 + 433 dynes • sec 
• cm -5 vs midpoint 1050 _+ 330 dynes • sec • cm -5, 
p < 0.01; control vs maximum 826 + 320 dynes, sec 
. cm -5, p < 0.01; and midpoint vs maximum, p < 
0.01) and E a (control 2.00 _+ 0.75 mm Hg/ml vs 
midpoint 1.60 _+ 0.53 mm Hg/ml, p < 0.01; control 
vs maximum 1.31 _+ 0.46 mm Hg/ml, p < 0.01; and 
midpoint vs maximum, p < 0.01). Although the 
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Fig. 3. Changes of hemodynamic parameters during protamine-induced hypotension. Results are shown 
for each point with averaged raw data for each of the 21 patients. 
slight decrease in E~s at midpoint (control 3.08 _+ 
1.61 mm Hg/ml vs midpoint 2.92 + 1.68 mm Hg/ml) 
did not reach statistical significance, Ees decreased 
significantly from control (p < 0.01) and from 
midpoint (p < 0.01) at the maximum point (2.63 _+ 
1.46 mm Hg/m!). HR, CI, Ped, and V e did not 
change significantly. The data regarding percentage 
change, Pes, dP/dt, and Ea/ges are summarized in 
Table II. 
Effects of each parameter on hypotension. The 
percentage changes from the each control value in 
MAP during hypotension correlated well with 
changes in SVR and E a (Fig. 4). On the other hand, 
there were no correlations between the percentage 
changes in MAP and changes in E~s and V e. 
Because Pes, as determined by single-beat estima- 
tion, was close to MAP (Pes = 0.97 MAP + 24.3, r = 
0.80, p < 0.001, standard error of estimate 2.7 mm 
Hg), we evaluated the effect of each parameter on 
Pes as a substitute for MAP. TM This is summarized in
Fig. 5. There were negative ffects on P~ in response 
to decreases inE~ and Ea. Potential decreases inEe~ 
at midpoint and maximum would reduce Pes by 1.8 
+ 4.4 mm Hg (not significant) and 4.5 -+ 7.1 mm Hg 
(p < 0.01), respectively, provided there were no 
changes in the other parameters. Greater potential 
effects of E a would be observed at both midpoint 
(10.0 _+ 6.6 mm Hg, p < 0.01) and maximum (19.3 _+ 
9.9 mm Hg, p < 0.01). Because there was no 
significant change in V~ during hypotension, the 
changes in Ve did not have any significant effect on 
PeS" 
Compression of the femoral arteries. Systemic 
arterial pressure was increased about 10 to 20 mm 
Hg with compression of the femoral arteries during 
protamine-induced hypotension. The hemodynamic 
parameters before and after compression of the 
femoral arteries in the seven patients treated this 
way were summarized in Table III. SVR and E a 
were increased significantly with compression of the 
femoral arteries, thereby increasing MAP signifi- 
cantly. HR, CI, Ped, Ve, and Ees did not change 
significantly. 
Discussion 
In this study, the hemodynamic changes of prota- 
mine-induced hypotension in patients who were 
separated from CPB occurred at 80 to 120 seconds 
after protamine administration at a constant rate 
over 180 seconds. During this period, as shown in 
Figs. 2 and 3, MAP, SVR, and E a rapidly decreased, 
whereas the other parameters, including HR, Ped, 
Ve, and CI, remained relatively unchanged. Al- 
though the load-insensitive parameter of contractil- 
ity, Ees, decreased significantly at the end of this 
period, continuous measurement of these changing 
parameters howed that the change in E~s was 
always preceded by the changes in MAP, SVR, and 
E a. The concept of ventricular-arterial coupling 
predicts that decreases in both E a and E~ will 
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Fig. 4. Relationships between percentage changes from each control value in MAP (%MAP) and changes 
in E a (%Ea) , ges (%Ees), SVR (%SVR), or V e (%Ve) during protamine-induced hypotension. %MAP had 
significant correlations with %SVR (dashed line; y = 0.55x + 36.9, r = 0.74, p < 0.001, standard error of 
the estimate 5.7%) and with %E, (dashed line; y = 0.47x + 39.9, r = 0.60,p < 0.001, standard error of the 
estimate 7.5%). Neither %E~ nor %V~ had any significant correlation with %MAP. 
Table II. Summary of hemodynamic parameters during protamine-induced hypotension 
Control Midpoint Maximum p 
MAP (ram Hg) 79.6 +_ 12.6 66.5 -+ 10.8" 52,7 +_ 9.9") <0.01 
SVR (dynes - sec. cm 5) 1359 +_ 434 1050 _+ 330* 826 ± 320"? <0.01 
Ea (mm Hg/ml) 2.00 -+ 0.75 1.60 _+ 0.53* 1.31 _+ 0.46*? <0.01 
%E a (%) 100 81.8 -+ 10.7" 67.2 + 13.4"t <0.01 
Ees (mm Hg/ml) 3.08 ± 1.61 2.92 ± 1.68 2.63 -+ 1.46"t <0.01 
%E~,~ (%) 100 94.9 -+ 10.5 87.5 ± 14.5"$ <0.01 
dP/dt (mm Hg/sec) 1647 _+ 523 1587 ± 509 1484 + 534"? <0.01 
Pos (ram Hg) 103.0 +_ 14.7 87.2 ± 14.6" 71.4 ± 13.8"? <0.01 
Ea/Ee~ 0.88 ± 0.66 0.75 -+ 0.58 0.65 -+ 0.44* <0.01 
HR (beats/min) 83.0 _+ 15.3 82.6 ± 14.6 81.4 ± 14.1 NS 
Ped (mm Hg) 11.0 ± 2.9 10.5 _+ 2.9 10.1 _+ 2.9 NS 
Ve (ml) 90.4 ± 49.2 88.9 + 44.3 86.5 + 36.5 NS 
CI (L • ±in -* - m 2) 2.94 _+ 0.73 3.08 +- 0.73 3.04 _+ 0.69 NS 
%E~ Percentage change of Ea from control value; %Ee,, percentage change Ees from control value; NS, not significant. Values are expressed as mean _+ 
standard eviation; p values obtained by repeated-measures analysis of variance with Bonferroni's adjustment. 
*p < 0.01 vs. control. 
tp < 0.01 vs midpoint. 
$<0.05 vs midpoint. 
decrease arterial pressure. In our studies, there were 
greater potential effects of E a than those of Ees, and 
the decrease in MAP correlated well with the de- 
creases in SVR and E a but not with that in Ees (Figs. 
4 and 5). These results suggest that the possible 
mechanism by which protamine induces hypoten- 
sion is afterload reduction through its vasodilatory 
effect. 
Left ventricular ESPVR is nearly linear across the 
working range of the heart, and the slope of this 
relationship (Ees) reflects contractile state. Ees is 
therefore considered a load-insensitive parameter of 
contractility on the basis of studies with isolated 
heart preparat ionsY Analysis of left ventricular 
ESPVR in human beings has been hindered, how- 
ever, by difficulties in simultaneous measurement of 
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Fig. 5. Leftpanel: Bar graph showing decreased MAP at 
midpoint and maximum during protamine-induced hypo- 
tension. Right paneh Bar graph showing effect of each 
parameter on the change in Pe~. APes describes the effect 
of a change in a parameter on the Pes, provided that the 
other two parameters remain at their control values. 
left ventricular pressure and volume under altered 
loading conditions. In several studies in human 
beings, 24-26 left ventricular volume and pressure 
were measured by cardiac atheterization, radionu- 
clide angiography, or a conductance catheter. The 
ESPVR was constructed by altering the loading 
conditions, under the assumption that the contrac- 
tile state was not affected by neurohumoral control 
mechanisms during alterations in loading, which 
may not actually be the case. In addition, continuous 
assessment of ESPVR in a beat-to-beat fashion has 
not been available. Moreover, these volumetric 
methods, with the exception of the Conductance 
catheter, are not available in the operating room. 
We therefore applied the method previously used to 
assess E~s of the in situ canine heart is' 19 to patients 
who underwent heart operations. We estimated 
Pm~x from a given ejecting beat with the curve-fitting 
technique (Fig. 1). 15' 16. 2o The validity of the esti- 
mate of Pmax and Ee~ was not tested in human 
beings. We did, however, examine the relationship 
between Ees calculated by this method and Ees 
measured by actual aortic crossclamping in 17 ca- 
nine hearts, is The estimated and measured Pmax of 
232 beats in various loading conditions were com- 
pared, and the correlation coefficient was 0.92. The 
estimation error of the Ees obtained by this method 
relative to that obtained by actual aortic crossclamp- 
ing was approximately 10%. Takeuchi and cowork- 
ers 16 have validated independently the similar 
Table IlL Hemodynamic parameters before and 
after compression of the femoral arteries 
t~efore After 
MAP (mm Hg) 53.8 -+ 7.2 68.0 -+ 9.3* 
SVR (dynes • sec • cm -s) 954 +_ 357 1216 _+ 358* 
Ea (mm Hg/ml) 1.30 _+ 0.47 1.67 _+ 0.53* 
Ees (mm Hg/ml) 2.78 -+ 1.89 2.79 -+ 1.80 
HR (beats/min) 78.8 + 18.6 81.7 _+ 18.8 
Ped (mm Hg) 9.7 -+ 2.9 9.9 -+ 3.5 
V c (ml) 85.2 _+ 46.4 92.1 _+ 55.0 
CI (L • min -1 • m 2) 2.63 _+ 0.89 2.62 _+ 0.90 
Values expressed as mean -+ standard eviation. 
*p < 0.01. 
method in patients by measuring ventricular volume 
with angiography. We therefore considered the es- 
timated Pmax and Ees to be acceptable. Simultaneous 
measurements of aortic flow and left ventricular 
pressure, combined with the estimation of Pmax, 
enabled us to assess Ees in a beat-to-beat fashion 
under changing hemodynamic conditions. 
The concept of ventricular-arterial coupling is 
based on the framework of ventricular pressure- 
volume relationship. TM This coupling was made pos- 
sible by characterizing the linear functions of both 
the ventricle and the arterial system in terms of their 
Pes and SV (Pes-SV) relationships. This approach 
yielded Pes and SV as the intersection between the 
ventricular Pe~-SV relationship and arterial Pes-SV 
relationship. Accordingly, as described in the Meth- 
ods section, Pes can be predicted by a simple equa- 
tion consisting of three parameters representing 
preload, afterload, and systolic function. From the 
equation, the effects of Ees and E a on Pe~ are 
summarized as follows: (1) If Ees is equal to Ea, the 
changes in Ees and E a have equivalent effect on P~s. 
(2) If Ees is greater than E~, the changes in Ees have 
a smaller effect on Pes than do the changes in E~. (3) 
If Ees is less than Ea, the changes in Ee~ have a larger 
effect on P~s than do the changes in E a. In this study, 
the control value of E~ was smaller than E~. In 
addition, the absolute changes in E a were larger. 
The net effect of E a on Pes was therefore larger than 
the effect of Ees, as shown in Fig. 5. Decreases inEes 
represent depression of myocardial contractility, 
whereas decreases in E~ reflect more complex phys- 
iologic responses. Because Ea can be approximated 
by the ratio of total arterial resistance to cardiac 
cycle length, 14 relative changes in these two factors 
determine Ea. During protamine-induced hypoten- 
sion, cardiac cycle length did not change signifi- 
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cantly. The decreases in E a in this study therefore 
represented decreases in arterial resistance. 
The concept of ventricular-arterial coupling also 
provides information about ventricular mechanical 
and metabolic efficiencyY When the Ea/Ees ratio 
lies between 0.5 and 1.0, both mechanical and 
metabolic efficiencies are greater than 90% of opti- 
mal values in the analytic model. Asanoi, Sasayama, 
and Kameyama 28suggested that the coupling was 
normally set toward higher metabolic efficiency (the 
Ea/E~s ratio toward 0.5) in human beings. In our 
study, despite a relatively large amount of patient- 
to-patient variability, the mean Ea/Ees ratio at con- 
trol was 0.88 +_ 0.66, and this was comparable to the 
values (0.90 +_ 0.21) reported by Asanoi, Sasayama, 
and Kameyama 2sfor patients with mild left ventric- 
ular dysfunction. 
Adverse cardiovascular responses to protamine 
have been reported to fall into three distinct ypes: 
transient hypotension, anaphylactoid reactions, and 
catastrophic pulmonary vasoconstriction. 1 There 
may be complex mechanisms inducing such variable 
responses. Anaphylactoid reactions were not seen in 
the 35 patients in our study. Although not all 
patients had been monitored for pulmonary artery 
pressure, pulmonary arterial hypertension was not 
seen in the monitored patients and no respiratory 
problems were seen in the other patients. Conse- 
quently, we decided that we could analyze prota- 
mine-induced transient hypotension in our study. 
Because not all patients had induced hypotension 
(Table I), variability in patient response to prota- 
mine may exist. We included several different ypes 
of procedures in the study, which may have influ- 
enced the variability. With respect o the composi- 
tion of the procedures, we could not include coro- 
nary artery bypass grafting because the method used 
for measurement requires an electromagnetic flow 
probe to be placed around the ascending aorta. 
The mechanisms of protamine-induced hypoten- 
sion have not been clearly defined. ~ Dose-related 
direct negative inotropic effects of protamine have 
been reported in both human 7 and porcine 13 iso- 
lated muscle preparations. In an isolated rabbit 
heart preparation, protamine had dose- and time- 
specific adverse effects on cardiac contractility. 12
There may be differences between findings in iso- 
lated heart preparations and those in in vivo studies, 
where neurohumoral reflexes can minimize prota- 
mine-induced vasodilation; effects of protamine on 
myocardial function were reported as positive ino- 
tropic changes, 9 negative inotropic changes, 1° or no 
changes lj in several in vivo animal studies. As 
reported by Jaques, 8 marked variations in prota- 
mine toxicity were observed among species used for 
experimentation. I  addition, the influence of CPB 
was not involved in the studies on small animals. 
Several authors reported that protamine in their 
clinical studies had certain effects on the myocardial 
function or the peripheral vascular beds, z-4 whereas 
others reported no effects. 5'6 We observed both 
depressed myocardial contractility and vasodilation, 
and we quantitatively showed the greater potential 
effect of vasodilation than depressed contractility. 
Shapira and associates 3 continuously recorded the 
hemodynamic parameters in a human study, and 
their results were generally compatible with ours. 
Because they observed a decrease in myocardial 
contractility simultaneous with the decrease in 
blood pressure, they suggested that the depressed 
myocardial contractility was a direct effect of prota- 
mine. In our study, however, decreased contractility 
was preceded by decreases in MAP and afterload. 
Consequently, a delayed ecrease in contractility at 
the end of hypotensive period seems to be ascribable 
to two possible mechanisms. One possible explana- 
tion is exhausted coronary autoregulatory reserve at 
the end of hypotension, which might be below a 
level of critical coronary perfusion pressure. 29 The 
other is the direct effect of protamine because the 
decreased contractility did not increase with the 
moderate increase in MAP by the femoral artery 
compression technique (Table III). The isovolumic 
measurements of myocardial contractile element 
velocity that Shapira and associates 3 used as an 
index of contractility have been reported to lack 
sufficient stability during acute changes in loading 
conditions. 3° The difference in used indexes of con- 
tractility may have contributed to the difference. 
Our conclusion that protamine-induced hypoten- 
sion was initially caused by decreased afterload was 
partially verified by use of the femoral artery com- 
pression technique. As shown in Table III, MAP, Ea, 
and SVR were increased by simply compressing the 
bilateral femoral arteries with the fists, leaving 
other parameters unchanged. Several interventions 
against protamine-induced hypotension have been 
reported. Those include pretreatment with calcium 
chloride, infusion of inotropics, volume loading, and 
combinations of these interventions. 9 Because this 
hypotension is usually transient, as reported by 
Shapira and associates, 3 such interventions may not 
be always required. Patients with good cardiac func- 
tional reserve may tolerate this hypotensive condi- 
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tion, but patients with poor cardiac functional re- 
serve may, because reduced coronary perfusion 
pressure impairs myocardial contractility, show fur- 
ther deterioration if an appropriate intervention is
not performed. 29Compression of the femoral arter- 
ies provided prompt recovery of MAP and thus 
would increase coronary perfusion pressure. Re- 
cently, we have routinely used this simple and 
effective method to treat protamine-induced hypo- 
tension by maintaining coronary perfusion pressure. 
Certain limitations of this study should be men- 
tioned. First, recent studies questioned the load 
independence and linearity of ESPVR under a 
variety of conditions. TM 32 Little and coworkers, 33 
however, reported that a consistent nonlinearity 
present at all inotropic states did not prevent 
ESPVR from being well approximated by a straight 
line and that Ees provided a sensitive parameter of 
contractile state. We reported elsewhere that the 
average variance of the Ees measured by actual 
aortic crossclamping in the canine heart during 
volume loading within the physiologic range was 
small enough to be negligible. 19 We therefore con- 
sider ESPVR to be acceptable for measuring con- 
tractility. Second, under changing hemodynamic 
conditions with decreasing afterload, ejecting ven- 
tricular pressure may be modulated by a changing 
relationship between ventricle and arterial system. 
The ventricular pressure curve of relaxation phase 
was also reported to be dependent on afterload. 21 
We did not use the pressure curve of the isovolumic 
relaxation phase, however, but instead used that of 
the isovolumic ontraction phase in our single-beat 
estimation method. Accordingly, the estimated Ees 
would be relatively insensitive to changes in ventric- 
ular pressure during ejection and relaxation. Third, 
Ea was originally defined as a steady-state arterial 
parameter that incorporates the principal elements 
of vascular load. 14 Because of the viscoelastic prop- 
erties of the arterial system, the accuracy of estimat- 
ing Ea in a beat-to-beat fashion during decreasing 
arterial pressure is controversial. Because we 
adopted the measured parameters at maximum, 
however, when arterial pressure had reached a 
nadir, at least the points of control and maximum 
were considered to be at a steady state. Only with 
these two sets of data could we make the same 
conclusion regarding the contribution analysis in a 
quantitative manner (Fig. 5; control vs. maximum). 
Fourth, we could not analyze the data for seven of 
28 hypotensive patients because of electrical noise in 
the flow signals. Although changing hemodynamic 
patterns of acquired pressure data for these seven 
patients were not different from those in 21 analyzed 
patients, it is unknown whether exclusion of 25% of 
the patients might have affected results and conclu- 
sions. Finally, because the volume axis intercept of 
the ESPVR line (V0) could not be measured by our 
method, we applied V e to substitute for Ved. Even if 
V 0 was changed uring the hypotension, the ventric- 
ular Pes-SV relation and arterial Pes-SV relation 
merely moved parallel along the volume axis, so the 
change in V0 would not influence the coupling of 
these relations. 
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